What You Should Know:
- ChristianaCare recently announced it has spun out its first commercial biotechnology private startup company, named CorriXR Therapeutics. The company will use CRISPR gene editing technology to develop new, clinically relevant oncologic therapeutics in areas of unmet medical need, starting with squamous cell carcinoma of the lung. Its close relationship with ChristianaCare and the ChristianaCare Gene Editing Institute uniquely positions it to research and develop
Read More
Startups| Digital Health | | Health IT News, Analysis, Insights - HIT Consultant
FOLX Health Raises $30M, Launches Expert-Led Support Groups for LGBTQIA+ Community
What You Should Know:
- FOLX Health, the first digital healthcare service provider designed by and for the medical needs of the LGBTQIA+ community, today announced $30M in new financing led by 7wireVentures, with participation from new investor Foresite Capital and existing investors, including Bessemer Venture Partners, Define Ventures, and Polaris Partners.
- Lee Shapiro, Managing Partner of 7wireVentures and former Chief Financial Officer of Livongo Health, will join FOLX Health’s Board
Read More
Pleno Secures $40M to Disrupt Sequencing Market, Scale Multi-omics
What You Should Know:
- Pleno, Inc, a multi-omic instrument platform company revolutionizing biological target detection for clinical testing and biomedical research raises $40M in Series A funding led by Deerfield Management and Foresite Capital.
- The funding will accelerate the development of Pleno’s Hypercoding™ instrument platform, called RAPTOR ™, which is slated for early customer access in 2023 and full availability in 2024. Release below
Read More
Brave Health Raises $40M for Medicaid Virtual Health Platform
What You Should Know:
- Brave Health, a virtual mental health provider and engagement platform focused on serving Medicaid populations raises $40M in Series C funding round led by Town Hall Ventures, with existing investors Union Square Ventures, City Light Capital and others joining as well. The company has raised a total of $60M to date, and this most recent funding will support their continued expansion into value-based care arrangements and into new and existing markets.
- Brave
Read More
Grow Therapy Raises $75M to Expand Insurance Coverage for Mental Healthcare Nationwide
What You Should Know:
- Behavioral health company, Grow Therapy secures $75 million in series B funding to expand insurance coverage including Medicare and Medicaid in all 50 states.
- This round of funding was led by TCV, co-led by Transformation Capital, with support from existing backers SignalFire and SVB.
Medicare/Medicaid Coverage Expansion
Specifically, the areas that the company will focus on are: expanding commercial insurance and Medicare and Medicaid coverage (which are
Read More
Kahun Secures $8M for Clinical Reasoning Engine
What You Should Know:
- Kahun, an evidence-based clinical reasoning tool for physicians, raises $8 million in a seed funding round led by LocalGlobe with the participation of European Innovation Council (EIC) Fund as part of the EIC Accelerator program and The Founders Kitchen (TFK).
- Kahun will leverage the funding to continue building the largest ever map of evidence-based medical knowledge powered by AI. The funds will be used to continue adding new sub-specialties beyond primary
Read More
Qnovia Secures $17M to Advance Inhalable Therapeutics Pipeline
What You Should Know:
- Qnovia (formerly Respira Technologies)—a pharma company developing inhaled therapeutics with an initial focus on nicotine replacement therapy (NRT) and cardiopulmonary diseases—has raised $17M in Series A funding led by Blue Ledge Capital and included DG Ventures, Evolution VC Partners, Gaingels, TL Capital, and Vice Ventures.
- Qnovia will use the Series A proceeds to advance its NRT drug candidate through an IND submission with the FDA and begin human
Read More
Rippl Launches with $35M to Transform Mental Health for Seniors
What You Should Know:
- Rippl, a new mental health startup focused on caring for seniors with dementia and other neurocognitive conditions, launched today with $32M in seed round funding led by ARCH Venture Partners and General Catalyst. The round also includes investment from GV, F-Prime Capital, and Mass General Brigham Ventures.
- Rippl will use its seed funding to hire and train a team of clinicians, build technology, and open a Washington state-based clinical support center to launch
Read More
Optellum Raises $14M for AI-Enabled Lung Cancer Diagnosis
What You Should Know:
- Optellum, an Oxford-based digital health company that provides a breakthrough AI platform to diagnose and treat early-stage lung cancer raises $14M in Series A funding led by Mercia, with additional investors Intuitive Ventures and Black Opal Ventures. Existing investors, including St John's College in the University of Oxford, IQ Capital, and the family office of Sir Martin & Lady Audrey Wood, also participated in this round.
- The investment will enable
Read More
Tavros Therapeutics Raises $7.5M to Develop Targeted Cancer Therapies
What You Should Know:
- Tavros Therapeutics, a precision oncology platform company leading the new frontier of targeted therapies exploiting tumors’ genetic vulnerabilities raises $7.5 million in Seed II financing co-led by existing investor Piedmont Capital Investments and new investor KdT Ventures, with participation from Alexandria Venture Investments.
- Tavros launched in 2020 with a $3 million seed financing by Piedmont Capital Investments and a strategic collaboration with Zentalis
Read More
